| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/25/2013 | CN103463211A Sugar-free prepared multiflower knotweed tuber granules, preparation method and quality control method thereof |
| 12/25/2013 | CN103463207A Composition for prevention and treatment of diabetes |
| 12/25/2013 | CN103463198A Traditional Chinese medicine composition for treating diabetes |
| 12/25/2013 | CN103463194A Oral anti-diabetic agent |
| 12/25/2013 | CN103463175A Pharmaceutical composition for preventing birth defects and improving memory |
| 12/25/2013 | CN103463174A Compound drug for treating microcytic anemia and preparation method thereof |
| 12/25/2013 | CN103463173A Healthcare bathing medicine and medicine liquid and preparation method thereof |
| 12/25/2013 | CN103463171A Pharmaceutical composition for preventing birth defects and improving memory |
| 12/25/2013 | CN103463169A Pharmaceutical composition for preventing birth defects and improving memory |
| 12/25/2013 | CN103463167A Pharmaceutical composition for preventing birth defects and improving memory |
| 12/25/2013 | CN103463155A Pharmaceutical composition used for preventing birth defects and improving memory |
| 12/25/2013 | CN103463148A Compound preparation containing pseudo-ginseng |
| 12/25/2013 | CN103463129A Pharmaceutical composition used for preventing birth defects and improving memory |
| 12/25/2013 | CN103463127A Sodium acetate ringer injection and preparation method thereof |
| 12/25/2013 | CN103463126A Calcium carbonate D3 granula and preparation method thereof |
| 12/25/2013 | CN103463122A Compound fluorouracil injection as well as preparation method thereof |
| 12/25/2013 | CN103463120A Stable-type composite vitamin B tablet and preparation method thereof |
| 12/25/2013 | CN103463113A Celecoxib amorphous condensate and preparation method thereof |
| 12/25/2013 | CN103463100A Application of Kadcoccitones A in preparing medicament for reducing blood sugar |
| 12/25/2013 | CN103463094A Medicine composition of cefpiramide sodium and infant compound amino acid injection (19AA-I) |
| 12/25/2013 | CN103463090A Preparation method of sitagliptin metformin hydrochloride compound preparation |
| 12/25/2013 | CN103463077A Application of Lycojaponicumin C in medicine for promoting insulin secretion |
| 12/25/2013 | CN103463038A Application of Lycojaponicumin A in insulinotropic hormone excretion medicaments |
| 12/25/2013 | CN103463031A Application of Lycojaponicumin B in medicine for promoting insulin secretion |
| 12/25/2013 | CN103463013A Preparation process of high-concentration compound amino acid injection |
| 12/25/2013 | CN103462986A Application of spirooliganones B in preparation of medicine reducing blood glucose |
| 12/25/2013 | CN103462965A Application of Incarviatone A in insulinotropic hormone excretion medicaments |
| 12/25/2013 | CN103462947A Calcium zinc gluconate granules and preparation method thereof |
| 12/25/2013 | CN103462937A Preparation method of spansules containing large dosage of nicotinic acid |
| 12/25/2013 | CN103462923A Double layer sustained release tablet for treatment of hyperlipidemia |
| 12/25/2013 | CN103462916A Vitamin C chewable tablet and preparation method thereof |
| 12/25/2013 | CN103462913A Galenic formulations of organic compounds |
| 12/25/2013 | CN103462903A Combination method and preparation process of pioglitazone hydrochloride sustained-release pellet preparation |
| 12/25/2013 | CN103462900A Metformin hydrochloride dry suspension and preparation method thereof |
| 12/25/2013 | CN103462890A Method for reducing value of anisidine in emulsion for injection |
| 12/25/2013 | CN103462887A Vitamin K1 injection and preparation method thereof |
| 12/25/2013 | CN103462009A Traditional Chinese medicine extract for assisting reduction of blood fat and preparation method thereof |
| 12/25/2013 | CN103461980A Health food with function of adjusting blood fat |
| 12/25/2013 | CN103461979A Health food |
| 12/25/2013 | CN103461978A Health food |
| 12/25/2013 | CN103461972A Health care food |
| 12/25/2013 | CN102861187B Weight-reducing aid |
| 12/25/2013 | CN102860996B Method for preparing lycoypene microcapsule |
| 12/25/2013 | CN102824599B Traditional Chinese medicine tincture for treating various skin eruptions caused by diabetes |
| 12/25/2013 | CN102784316B Cancer inhibition and flesh engendering medicine for treating burns, scalds, internal and external ulcer and cataract, and its preparation method |
| 12/25/2013 | CN102755530B Traditional Chinese medicine composition for treating diabetic foot and application thereof |
| 12/25/2013 | CN102698039B Pine needle tea beverage |
| 12/25/2013 | CN102697962B Lymph static defatting weight-losing paste |
| 12/25/2013 | CN102697939B Traditional Chinese medicine foot bath solution for preventing diabetic foot and preparation method thereof |
| 12/25/2013 | CN102688497B Preparation method of polypeptide zinc-ferrum supplementary |
| 12/25/2013 | CN102655764B Agent for increasing body weight, animal feed for increasing body weight and health food for increasing body weight |
| 12/25/2013 | CN102614359B Traditional Chinese medicine preparation for treating diabetes and preparation method thereof |
| 12/25/2013 | CN102504006B Steroid saponin compound in siberian fritillary bulb |
| 12/25/2013 | CN102272120B Biologically active amides |
| 12/25/2013 | CN102234336B Fucoidan-galactosan sulfate, extracting, separating, and purifying method thereof, and application thereof |
| 12/25/2013 | CN102174046B Tetomilast polymorphs |
| 12/25/2013 | CN102049048B Method of treatment or prophylaxis |
| 12/25/2013 | CN101835737B Spiro-ring compound and use thereof for medical purposes |
| 12/25/2013 | CN101787073B Methods and compositions for treatment of gastrointestinal disorders |
| 12/25/2013 | CN101754962B N-azacyclic substituted pyrrole, imidazole, triazole and tetrazole derivatives as agonists of RUP3 or GPR119 for treatment of diabetes and metabolic disorders |
| 12/25/2013 | CN101573048B Use of nutritional compositions for preventing disorders |
| 12/25/2013 | CN101432277B Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 12/24/2013 | US8614320 Preparation of aminopyrimidine compounds |
| 12/24/2013 | US8614292 Isolated protein comprising an activin type IIB5 receptor polypeptide and uses thereof |
| 12/24/2013 | DE112012001540T5 Arzneimittelverbindung für die Kontrolle von Blut-Glucose, Blutfetten und Gewicht Drug compound for the control of blood glucose, blood lipids and weight |
| 12/24/2013 | CA2714181C Ampk modulators |
| 12/24/2013 | CA2605510C Inhibitors of microsomal triglyceride transfer protein and apo-b secretion |
| 12/24/2013 | CA2602787C Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 12/24/2013 | CA2583756C Pharmaceutical composition comprising microcapusles of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa) |
| 12/24/2013 | CA2575787C Dihydropteridinones for the treatment of cancer diseases |
| 12/24/2013 | CA2464199C A composition and method to alter lean body mass and bone properties in a subject |
| 12/24/2013 | CA2375104C Prevention and treatment of amyloidogenic disease |
| 12/22/2013 | CA2817910A1 Compound for treating hypocalcaemia in ruminants |
| 12/19/2013 | WO2013187646A1 Piperidine derivatives for gpr119 agonist |
| 12/19/2013 | WO2013187575A1 Composition comprising hypothemycin as active ingredient for preventing and treating macrophage activation syndrome, hepatocirrhosis, or obesity |
| 12/19/2013 | WO2013187533A1 Heteroarylcarboxylic acid ester derivative |
| 12/19/2013 | WO2013187467A1 Heteroaromatic methyl cyclic amine derivative |
| 12/19/2013 | WO2013187462A1 Piperidinylpyrazolopyridine derivative |
| 12/19/2013 | WO2013187391A1 COMPOSITION COMPRISING SESAMIN COMPOUND, γ-ORIZANOL AND RICE GERM OIL |
| 12/19/2013 | WO2013187381A1 Method for producing ppar activator, and ppar activator |
| 12/19/2013 | WO2013186680A1 Feijoa fruit extract |
| 12/19/2013 | WO2013186326A1 NEW SYNTHETIC ROUTE FOR THE PREPARATION OF ß-AMINOBUTYRYL SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,4]DIAZOLO[4,3-alpha]PYRAZIN-7-YL COMPOUNDS |
| 12/19/2013 | WO2013186138A1 Preparation comprising insulin, nicotinamide and arginine |
| 12/19/2013 | WO2013186109A1 2,3-dihydro-furo[2,3-c]pyridin-2-yl-piperidine derivatives, pharmaceutical compositions containing them and uses thereof |
| 12/19/2013 | WO2013185766A1 Gpr120 receptor modulators |
| 12/19/2013 | WO2013185284A1 Pyridinone and pyridazinone derivatives |
| 12/19/2013 | WO2013185235A1 Targeted iduronidase compounds |
| 12/19/2013 | US20130338188 Pharmaceutical compositions and administrations thereof |
| 12/19/2013 | US20130338132 Heteroarylcarboxylic acid ester derivative |
| 12/19/2013 | US20130338063 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 12/19/2013 | US20130337041 Charged phospholipid compositions and methods for their use |
| 12/19/2013 | DE102010023850B4 Funktionalisierte Nanopartikel mit verbesserter Bioverfügbarkeit Functionalized nanoparticles with improved bioavailability |
| 12/19/2013 | CA2876573A1 Heteroarylcarboxylic acid ester derivative |
| 12/19/2013 | CA2876525A1 Targeted iduromdase compounds |
| 12/19/2013 | CA2876382A1 Piperidinylpyrazolopyridine derivative |
| 12/19/2013 | CA2876253A1 Heteroaromatic methyl cyclic amine derivative |
| 12/19/2013 | CA2875504A1 Feijoa fruit extract |
| 12/19/2013 | CA2874953A1 Pyridinone and pyridazinone derivatives |
| 12/18/2013 | EP2674432A1 New synthetic route for the preparation of ß aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha]pyrazin-7-yl compounds |
| 12/18/2013 | EP2674160A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |